2017-2022 Global and Japan Liver and Gallbladder disease drugs Market Analysis Report

August 2017 | 124 pages | ID: 25B25C8CCDDEN
JP Research

Abstracts

The global Liver and Gallbladder disease drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Liver and Gallbladder disease drugs market's development status and future trend in Japan, focuses on top players in Japan, also splits Liver and Gallbladder disease drugs market by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players include

• ABBOTT S.R.L.
• Alchem International Ltd
• Alkaloids Private Limited
• AR HOLDING CO INC
• ARCH PHARMALABS LIMITED Mumbai
• AUROBINDO PHARMA LIMITED Hyderabad
• CIPLA LIMITED Mumbai
• Daewoong Bio Inc.
• Dr. Falk Pharma GmbH
• Gedeon Richter Plc.
• GILEAD
• Glaxo Group Limited
• Hetero Labs Limited
• I.C.I. International Chemical Industry S.P.A
• Indena S.p.A. IT Milano
• INGENUS PHARMS NJ
• KYOWA HAKKO BIO CO., LTD. JP Tokyo
• LAURUS LABS LIMITED IN Hyderabad
• LUPIN LTD
• MYLAN LABORATORIES LIMITED IN Hyderabad
• Nichi-iko Pharmaceutical Co.,Ltd
• Sanmar Speciality Chemicals Limited IN Chennai
• Sawai Pharmaceutical Co.,Ltd.
• SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. CN Laogang Town
• SIGMAPHARM LABS LLC
• TAKATA SEIYAKU Co., Ltd.
• TEVA PHARMS USA
• VITAL LABORATORIES PVT. LIMITED IN Mumbai
• WATSON LABS
• Zeneses Biosciences Pvt.Ltd.

Geographically, this report splits the Japan market into 5 regions:

• Tokyo
• Yokohama
• Osaka
• Nagoya
• Others

On the basis of product, the Liver and Gallbladder disease drugs market is primarily split into

Liver and Gallbladder disease drugs Market, by Cholagogue

• Ursodeoxycholic acid
• Febuprol
• Anethol Trithione

Liver and Gallbladder disease drugs Market, by Drugs of Anti-hepatitis and p

• diammonium glycyrrhizinate
• Bicyclol
• glycyrrhizic acid monoammonium
• glutathione
• Silibinin
• polyunsaturated lecithin
• Diisopropylamine
• Osalmid
• inosine
• Potassium Magnesium Aspartate
• Glucurolactone
• Adenosine Disodium Triphosphate
• Transmetil
• Tiopronin
• Polyene Phosphatidyl Choline
• Colchicine
• Malotilate
• adefovir dipivoxil
• Lamivudine

Liver and Gallbladder disease drugs Market, by Others

• Probucol
• Bifendate
• methionine

Key Applications

• Hepatology
• Clinic
• Pharmacy

Contents

1 LIVER AND GALLBLADDER DISEASE DRUGS OVERVIEW

1.1 Product Overview and Scope of Liver and Gallbladder disease drugs
1.2 Japan Liver and Gallbladder disease drugs Market by Applications/End Users
  1.2.1 Japan Liver and Gallbladder disease drugs Sales () and Market Share Comparison by Applications (2012-2022)
  1.2.2 Hepatology
  1.2.3 Clinic
  1.2.4 Pharmacy
1.3 Japan Liver and Gallbladder disease drugs Market by Regions
  1.3.1 Japan Liver and Gallbladder disease drugs Market Size (Million USD) Comparison by Regions (2012-2022)
  1.3.2 Tokyo Liver and Gallbladder disease drugs Status and Prospect (2012-2022)
  1.3.3 Yokohama Liver and Gallbladder disease drugs Status and Prospect (2012-2022)
  1.3.4 Osaka Liver and Gallbladder disease drugs Status and Prospect (2012-2022)
  1.3.5 Nagoya Liver and Gallbladder disease drugs Status and Prospect (2012-2022)
  1.3.6 Others in Japan Liver and Gallbladder disease drugs Status and Prospect (2012-2022)
1.4 Japan Market Size (Sales and Revenue) of Liver and Gallbladder disease drugs (2012-2022)
  1.4.1 Japan Liver and Gallbladder disease drugs Sales () and Growth Rate (%)(2012-2022)
  1.4.2 Japan Liver and Gallbladder disease drugs Revenue (Million USD) and Growth Rate (2012-2022)
1.5 Classification of Liver and Gallbladder disease drugs by Cholagogue
  1.5.1 Japan Liver and Gallbladder disease drugs Sales () Comparison by Types (2012-2022)
  1.5.2 Japan Liver and Gallbladder disease drugs Sales () Market Share by Types in 2016
  1.5.3 Ursodeoxycholic acid
  1.5.4 Febuprol
  1.5.5 Anethol Trithione
1.6 Classification of Liver and Gallbladder disease drugs by Drugs of Anti-hepatitis and pr
  1.6.1 Japan Liver and Gallbladder disease drugs Sales () Comparison by Types (2012-2022)
  1.6.2 Japan Liver and Gallbladder disease drugs Sales () Market Share by Types in 2016
  1.6.3 diammonium glycyrrhizinate
  1.6.4 Bicyclol
  1.6.5 glycyrrhizic acid monoammonium
  1.6.6 glutathione
  1.6.7 Silibinin
1.7 Classification of Liver and Gallbladder disease drugs by Others
  1.7.1 Japan Liver and Gallbladder disease drugs Sales () Comparison by Types (2012-2022)
  1.7.2 Japan Liver and Gallbladder disease drugs Sales () Market Share by Types in 2016
  1.7.3 Probucol
  1.7.4 Bifendate
  1.7.5 methionine

2 JAPAN LIVER AND GALLBLADDER DISEASE DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Liver and Gallbladder disease drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 Japan Liver and Gallbladder disease drugs Revenue and Share by Players/Manufacturers (2012-2017)
2.3 Japan Liver and Gallbladder disease drugs Average Price () by Players/Manufacturers (2012-2017)
2.4 Japan Liver and Gallbladder disease drugs Market Competitive Situation and Trends
  2.4.1 Japan Liver and Gallbladder disease drugs Market Concentration Rate
  2.4.2 Japan Liver and Gallbladder disease drugs Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.5 Japan Players/Manufacturers Liver and Gallbladder disease drugs Manufacturing Base Distribution, Sales Area, Product Types

3 JAPAN LIVER AND GALLBLADDER DISEASE DRUGS SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Japan Liver and Gallbladder disease drugs Sales () and Market Share by Regions (2012-2017)
3.2 Japan Liver and Gallbladder disease drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
3.3 Japan Liver and Gallbladder disease drugs Price () by Regions (2012-2017)

4 JAPAN LIVER AND GALLBLADDER DISEASE DRUGS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 Japan Liver and Gallbladder disease drugs Sales () and Market Share by Type (2012-2017)
4.2 Japan Liver and Gallbladder disease drugs Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 Japan Liver and Gallbladder disease drugs Price () by Type (2012-2017)
4.4 Japan Liver and Gallbladder disease drugs Sales Growth Rate (%) by Type (2012-2017)

5 JAPAN LIVER AND GALLBLADDER DISEASE DRUGS SALES BY APPLICATION (2012-2017)

5.1 Japan Liver and Gallbladder disease drugs Sales () and Market Share by Applications (2012-2017)
5.2 Japan Liver and Gallbladder disease drugs Sales Growth Rate (%) by Applications (2012-2017)
5.3 Market Drivers and Opportunities

6 JAPAN LIVER AND GALLBLADDER DISEASE DRUGS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

6.1 ABBOTT S.R.L.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ABBOTT S.R.L. Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Alchem International Ltd
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alchem International Ltd Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Alkaloids Private Limited
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Alkaloids Private Limited Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 AR HOLDING CO INC
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AR HOLDING CO INC Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 ARCH PHARMALABS LIMITED Mumbai
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 ARCH PHARMALABS LIMITED Mumbai Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AUROBINDO PHARMA LIMITED Hyderabad
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AUROBINDO PHARMA LIMITED Hyderabad Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 CIPLA LIMITED Mumbai
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 CIPLA LIMITED Mumbai Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Daewoong Bio Inc.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Daewoong Bio Inc. Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Dr. Falk Pharma GmbH
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Dr. Falk Pharma GmbH Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Gedeon Richter Plc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Liver and Gallbladder disease drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Gedeon Richter Plc. Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 GILEAD
6.12 Glaxo Group Limited
6.13 Hetero Labs Limited
6.14 I.C.I. International Chemical Industry S.P.A
6.15 Indena S.p.A. IT Milano
6.16 INGENUS PHARMS NJ
6.17 KYOWA HAKKO BIO CO., LTD. JP Tokyo
6.18 LAURUS LABS LIMITED IN Hyderabad
6.19 LUPIN LTD
6.20 MYLAN LABORATORIES LIMITED IN Hyderabad
6.21 Nichi-iko Pharmaceutical Co.,Ltd
6.22 Sanmar Speciality Chemicals Limited IN Chennai
6.23 Sawai Pharmaceutical Co.,Ltd.
6.24 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. CN Laogang Town
6.25 SIGMAPHARM LABS LLC
6.26 TAKATA SEIYAKU Co., Ltd.
6.27 TEVA PHARMS USA
6.28 VITAL LABORATORIES PVT. LIMITED IN Mumbai
6.29 WATSON LABS
6.30 Zeneses Biosciences Pvt.Ltd.

7 LIVER AND GALLBLADDER DISEASE DRUGS MANUFACTURING COST ANALYSIS

7.1 Liver and Gallbladder disease drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liver and Gallbladder disease drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Liver and Gallbladder disease drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liver and Gallbladder disease drugs Major Players/Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 JAPAN LIVER AND GALLBLADDER DISEASE DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 Japan Liver and Gallbladder disease drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Japan Liver and Gallbladder disease drugs Sales () Forecast by Type (2017-2022)
11.3 Japan Liver and Gallbladder disease drugs Sales () Forecast by Application (2017-2022)
11.4 Japan Liver and Gallbladder disease drugs Sales () Forecast by Regions (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and Japan Market Size (Million USD) Comparison 2012-2022
Table Liver and Gallbladder disease drugs Sales () and Revenue (Million USD) Market Split by Cholagogue
Table Liver and Gallbladder disease drugs Sales () and Revenue (Million USD) Market Split by Drugs of Anti-hepatitis and pr
Table Liver and Gallbladder disease drugs Sales () and Revenue (Million USD) Market Split by Others
Table Liver and Gallbladder disease drugs Sales () by Application (2016-2022)
Figure Product Picture of Liver and Gallbladder disease drugs
Table Japan Liver and Gallbladder disease drugs Sales () Comparison by Applications (2012-2022)
Figure Japan Sales Market Share (%) of Liver and Gallbladder disease drugs by Applications in 2016
Figure Hepatology Examples
Table Key Downstream Customer in Hepatology
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Tokyo Liver and Gallbladder disease drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Yokohama Liver and Gallbladder disease drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Osaka Liver and Gallbladder disease drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Nagoya Liver and Gallbladder disease drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Others in Japan Liver and Gallbladder disease drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Liver and Gallbladder disease drugs Sales () and Growth Rate (%) (2012-2022)
Figure Japan Liver and Gallbladder disease drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table Japan Liver and Gallbladder disease drugs Sales () and Growth Rate (%) Comparison by Cholagogue (2012-2022)
Figure Japan Liver and Gallbladder disease drugs Sales Volume Market Share by Cholagogue in 2016
Figure Ursodeoxycholic acid Product Picture
Figure Febuprol Product Picture
Figure Anethol Trithione Product Picture
Table Japan Liver and Gallbladder disease drugs Sales () and Growth Rate (%) Comparison by Drugs of Anti-hepatitis and pr (2012-2022)
Figure Japan Liver and Gallbladder disease drugs Sales Volume Market Share by Drugs of Anti-hepatitis and pr in 2016
Figure diammonium glycyrrhizinate Product Picture
Figure Bicyclol Product Picture
Figure glycyrrhizic acid monoammonium Product Picture
Figure glutathione Product Picture
Figure Silibinin Product Picture
Table Japan Liver and Gallbladder disease drugs Sales () and Growth Rate (%) Comparison by Others (2012-2022)
Figure Japan Liver and Gallbladder disease drugs Sales Volume Market Share by Others in 2016
Figure Probucol Product Picture
Figure Bifendate Product Picture
Figure methionine Product Picture
Table Japan Liver and Gallbladder disease drugs Sales of Key Players/Manufacturers (2012-2017)
Table Japan Liver and Gallbladder disease drugs Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Japan Liver and Gallbladder disease drugs Sales Share (%) by Players/Manufacturers
Figure 2017 Japan Liver and Gallbladder disease drugs Sales Share (%) by Players/Manufacturers
Table Japan Liver and Gallbladder disease drugs Revenue by Players/Manufacturers (2012-2017)
Table Japan Liver and Gallbladder disease drugs Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Japan Liver and Gallbladder disease drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2017 Japan Liver and Gallbladder disease drugs Revenue Market Share (%) by Players/Manufacturers
Table Japan Market Liver and Gallbladder disease drugs Average Price of Key Players/Manufacturers (2012-2017)
Figure Japan Market Liver and Gallbladder disease drugs Average Price of Key Players/Manufacturers in 2016
Figure Japan Liver and Gallbladder disease drugs Market Share of Top 3 Players/Manufacturers
Figure Japan Liver and Gallbladder disease drugs Market Share of Top 5 Players/Manufacturers
Table Japan Players/Manufacturers Liver and Gallbladder disease drugs Manufacturing Base Distribution and Sales Area
Table Japan Players/Manufacturers Liver and Gallbladder disease drugs Product Category
Table Japan Liver and Gallbladder disease drugs Sales () by Regions (2012-2017)
Table Japan Liver and Gallbladder disease drugs Sales Share (%) by Regions (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Sales Share (%) by Regions (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Sales Market Share (%) by Regions in 2016
Table Japan Liver and Gallbladder disease drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Japan Liver and Gallbladder disease drugs Revenue Market Share (%) by Regions (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Revenue Market Share (%) by Regions (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Revenue Market Share (%) by Regions in 2016
Table Japan Liver and Gallbladder disease drugs Price (USD/Unit) by Regions (2012-2017)
Table Japan Liver and Gallbladder disease drugs Sales () by Type (2012-2017)
Table Japan Liver and Gallbladder disease drugs Sales Share (%) by Type (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Sales Share (%) by Type (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Sales Market Share (%) by Type in 2016
Table Japan Liver and Gallbladder disease drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Japan Liver and Gallbladder disease drugs Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Liver and Gallbladder disease drugs by Type (2012-2017)
Figure Revenue Market Share of Liver and Gallbladder disease drugs by Type in 2016
Table Japan Liver and Gallbladder disease drugs Price (USD/Unit) by Types (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Sales Growth Rate (%) by Type (2012-2017)
Table Japan Liver and Gallbladder disease drugs Sales () by Applications (2012-2017)
Table Japan Liver and Gallbladder disease drugs Sales Market Share (%) by Applications (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Sales Market Share (%) by Applications (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Sales Market Share (%) by Applications in 2016
Table Japan Liver and Gallbladder disease drugs Sales Growth Rate (%) by Applications (2012-2017)
Figure Japan Liver and Gallbladder disease drugs Sales Growth Rate (%) by Applications (2012-2017)
Table ABBOTT S.R.L. Basic Information List
Table ABBOTT S.R.L. Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table ABBOTT S.R.L. Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table ABBOTT S.R.L. Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure ABBOTT S.R.L. Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table Alchem International Ltd Basic Information List
Table Alchem International Ltd Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Alchem International Ltd Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table Alchem International Ltd Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure Alchem International Ltd Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table Alkaloids Private Limited Basic Information List
Table Alkaloids Private Limited Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Alkaloids Private Limited Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table Alkaloids Private Limited Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure Alkaloids Private Limited Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table AR HOLDING CO INC Basic Information List
Table AR HOLDING CO INC Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AR HOLDING CO INC Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table AR HOLDING CO INC Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure AR HOLDING CO INC Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table ARCH PHARMALABS LIMITED Mumbai Basic Information List
Table ARCH PHARMALABS LIMITED Mumbai Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table ARCH PHARMALABS LIMITED Mumbai Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table ARCH PHARMALABS LIMITED Mumbai Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure ARCH PHARMALABS LIMITED Mumbai Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table AUROBINDO PHARMA LIMITED Hyderabad Basic Information List
Table AUROBINDO PHARMA LIMITED Hyderabad Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table AUROBINDO PHARMA LIMITED Hyderabad Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table AUROBINDO PHARMA LIMITED Hyderabad Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure AUROBINDO PHARMA LIMITED Hyderabad Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table CIPLA LIMITED Mumbai Basic Information List
Table CIPLA LIMITED Mumbai Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table CIPLA LIMITED Mumbai Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table CIPLA LIMITED Mumbai Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure CIPLA LIMITED Mumbai Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table Daewoong Bio Inc. Basic Information List
Table Daewoong Bio Inc. Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Daewoong Bio Inc. Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table Daewoong Bio Inc. Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure Daewoong Bio Inc. Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table Dr. Falk Pharma GmbH Basic Information List
Table Dr. Falk Pharma GmbH Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Dr. Falk Pharma GmbH Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table Dr. Falk Pharma GmbH Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure Dr. Falk Pharma GmbH Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table Gedeon Richter Plc. Basic Information List
Table Gedeon Richter Plc. Liver and Gallbladder disease drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
Table Gedeon Richter Plc. Liver and Gallbladder disease drugs Sales Growth Rate (%)(2012-2017)
Table Gedeon Richter Plc. Liver and Gallbladder disease drugs Sales Market Share (%) in Japan (2012-2017)
Figure Gedeon Richter Plc. Liver and Gallbladder disease drugs Revenue Market Share (%) in Japan (2012-2017)
Table GILEAD Basic Information List
Table Glaxo Group Limited Basic Information List
Table Hetero Labs Limited Basic Information List
Table I.C.I. International Chemical Industry S.P.A Basic Information List
Table Indena S.p.A. IT Milano Basic Information List
Table INGENUS PHARMS NJ Basic Information List
Table KYOWA HAKKO BIO CO., LTD. JP Tokyo Basic Information List
Table LAURUS LABS LIMITED IN Hyderabad Basic Information List
Table LUPIN LTD Basic Information List
Table MYLAN LABORATORIES LIMITED IN Hyderabad Basic Information List
Table Nichi-iko Pharmaceutical Co.,Ltd Basic Information List
Table Sanmar Speciality Chemicals Limited IN Chennai Basic Information List
Table Sawai Pharmaceutical Co.,Ltd. Basic Information List
Table SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. CN Laogang Town Basic Information List
Table SIGMAPHARM LABS LLC Basic Information List
Table TAKATA SEIYAKU Co., Ltd. Basic Information List
Table TEVA PHARMS USA Basic Information List
Table VITAL LABORATORIES PVT. LIMITED IN Mumbai Basic Information List
Table WATSON LABS Basic Information List
Table Zeneses Biosciences Pvt.Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liver and Gallbladder disease drugs
Figure Manufacturing Process Analysis of Liver and Gallbladder disease drugs
Figure Liver and Gallbladder disease drugs Industrial Chain Analysis
Table Raw Materials Sources of Liver and Gallbladder disease drugs Major Players/Manufacturers in 2016
Table Major Buyers of Liver and Gallbladder disease drugs
Table Distributors/Traders List
Figure Japan Liver and Gallbladder disease drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Japan Liver and Gallbladder disease drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Liver and Gallbladder disease drugs Price () Trend Forecast (2017-2022)
Table Japan Liver and Gallbladder disease drugs Sales () Forecast by Type (2017-2022)
Figure Japan Liver and Gallbladder disease drugs Sales () Forecast by Type (2017-2022)
Figure Japan Liver and Gallbladder disease drugs Sales Volume Market Share Forecast by Type in 2022
Table Japan Liver and Gallbladder disease drugs Sales () Forecast by Application (2017-2022)
Figure Japan Liver and Gallbladder disease drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Japan Liver and Gallbladder disease drugs Sales Volume Market Share Forecast by Application in 2022
Table Japan Liver and Gallbladder disease drugs Sales () Forecast by Regions (2017-2022)
Table Japan Liver and Gallbladder disease drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Liver and Gallbladder disease drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Japan Liver and Gallbladder disease drugs Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources